Licensed weight-management medicines currently available in the UK include: Semaglutide (Wegovy) approved by the MHRA for chronic weight management in adults with a BMI of 30 kg/m or above, or 27 kg/m or above with at least one weight-related comorbidity
[4] Health Conditions: GLP-1 use is most common among those diagnosed with diabetes (43%), heart disease (26%), or obesity (22%) within the last five years
This helps lower blood sugar levels and improves glycemic control in individuals with diabetes
The calendar flips to a new year, and for many, its the familiar moment of reflection: This is the year I finally stick to my plan. Resolutions are made, meal plans are printed, workouts are scheduled, but by mid-January, progress stalls
Chen, S., Wang, X., Jin, Y., Chen, X., Song, Q., Wei, G., & Li, L
Aug 1989;12(4):345-53